BeOne Medicines (ONC) Other Non-Current Assets (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Other Non-Current Assets data on file, last reported at $104.2 million in Q1 2026.

• Quarterly Other Non-Current Assets fell 30.45% year-over-year to $104.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $104.2 million (down 30.45% YoY) and the FY2025 annual result came in at $102.4 million, down 36.18% from the prior year.
• Other Non-Current Assets rose to $104.2 million in Q1 2026 per ONC's latest filing, from $102.4 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $201.2 million in Q3 2024 and bottomed at $3.9 million in Q2 2022.
• The 5-year median for Other Non-Current Assets is $140.6 million (2022), against an average of $123.1 million.
• The widest annual swing landed in 2022, when Other Non-Current Assets slumped 60.32%; it then surged 2391.61% in 2023.
• Tracing ONC's Other Non-Current Assets over 5 years: stood at $75.1 million in 2022, then jumped by 66.89% to $125.4 million in 2023, then rose by 28.02% to $160.5 million in 2024, then slumped by 36.18% to $102.4 million in 2025, then advanced by 1.78% to $104.2 million in 2026.
• Per Business Quant, the three latest ONC Other Non-Current Assets figures stand at $104.2 million (Q1 2026), $102.4 million (Q4 2025), and $136.2 million (Q3 2025).

Peer Comparison